A study of depression among patients of substance use disorder
DOI:
https://doi.org/10.3126/jkmc.v1i2.8145Keywords:
Depression, ICD-10, substance use disorders.Abstract
Background: Depressive disorder is frequently found as a comorbidity among patients with substance abuse. Most of the time it is reported as underdiagnosed and a majority of patients go untreated. Many studies have indicated that comorbid depressive symptoms play a major role in the prognosis of substance use disorder and the relapse has been found to be greater in patients who have a comorbid depression. The present study seeks to determine the comorbidity of depression in cases with substance abuse and their sociodemographic characteristics.
Objective: The current study is aimed to determine the relationship between various drug abusing patterns and comorbidity of depression with substance use disorders.
Methods: This was a cross-sectional study. The study was carried out in 42 patients, who were consecutively admitted in psychiatric ward of Kathmandu Medical College Teaching Hospital and Punarjeevan Hospital with the diagnosis of mental and behavioural disorder due to use of psychoactive substances, according to ICD-10. The study was carried out from 1st January 2010 to 30th December 2010. All patients were rated using Hamilton Depression Rating Scale.
Results: Among all subjects, 31 (73.8 %) were found to be suffering from Depression among which 19 (45.2%) had mild to moderate depression and 12 (28.6%) had severe depression. Depression was seen among 80% of unemployed subjects, followed by 75% employed subjects and 68.8% students. In method of drug intake, 21 (50%) subjects used oral drugs, 12 (28.6%) subjects used intravenous route and 5 (11.9%) subjects used inhalational drugs. All patients using intravenous drugs were found to have depression. Among drugs abused, 22 (52.4%) patients used multiple substances like alcohol and cannabis, 11 (26.2%) patients used Heroin, 6 (14.3%) patients used drugs like Diazepam, Dextropropoxyphene, Nitrazepam and Promethazine, followed by 3 (7.1%) patients using Buprenorphine. Depression was found in 6 (54.54%) out of 11 subjects who used Heroin followed by 19 (86.63%) out of 22 subjects who were dependent on alcohol, cannabis and other substances.
Conclusion: The result showed strong correlation between depressive symptoms and substance abuse, which draws attention to the need of taking into consideration the comorbidity and its management. Clinicians should routinely assess for depression in patients with substance abuse disorders.
DOI: http://dx.doi.org/10.3126/jkmc.v1i2.8145
Journal of Kathmandu Medical College, Vol. 1, No. 2, Oct.-Dec., 2012: 96-99
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright © Journal of Kathmandu Medical College
The ideas and opinions expressed by authors or articles summarized, quoted, or published in full text in this journal represent only the opinions of the authors and do not necessarily reflect the official policy of Journal of Kathmandu Medical College or the institute with which the author(s) is/are affiliated, unless so specified.
Authors convey all copyright ownership, including any and all rights incidental thereto, exclusively to JKMC, in the event that such work is published by JKMC. JKMC shall own the work, including 1) copyright; 2) the right to grant permission to republish the article in whole or in part, with or without fee; 3) the right to produce preprints or reprints and translate into languages other than English for sale or free distribution; and 4) the right to republish the work in a collection of articles in any other mechanical or electronic format.